Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

CVD 103-HgR is a live oral cholera vaccine strain constructed by deleting 94% of the gene for the enzymatically active A subunit of cholera toxin from classical Inaba Vibrio cholerae O1 569B; the strain also contains a mercury resistance gene as an identifying marker. This vaccine was well tolerated...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Tacket, Carol O., Cohen, Mitchell B., Wasserman, Steven S., Losonsky, Genevieve, Livio, Sofie, Kotloff, Karen, Edelman, Robert, Kaper, James B., Cryz, Stanley J., Giannella, Ralph A., Schiff, Gilbert, Levine, Myron M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Microbial Immunity and Vaccines
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97039/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10569747/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.67.12.6341-6345.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!